Roflumilast: In Chronic Obstructive Pulmonary Disease

Author： Sanford Mark  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.70, Iss.12, 2010-08, pp. : 1615-1627

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Roflumilast: a guide to its use in chronic obstructive pulmonary disease

By  

Drugs & Therapy Perspectives, Vol. 27, Iss. 9, 2011-09 ,pp. : 6-10

Adis International

Access to resources Recommend Favorite

A 1-Year Prospective Cost-Effectiveness Analysis of Roflumilast for the Treatment of Patients with Severe Chronic Obstructive Pulmonary Disease

By Mölken Maureen P.M.H. Rutten-van  

PharmacoEconomics, Vol. 25, Iss. 8, 2007-01 ,pp. : 695-711

Adis International

Access to resources Recommend Favorite

Indacaterol: In Chronic Obstructive Pulmonary Disease

By Moen Marit D.  

Drugs, Vol. 70, Iss. 17, 2010-12 ,pp. : 2269-2280

Adis International

Access to resources Recommend Favorite

Pharmacogenetics of chronic obstructive pulmonary disease

By Hizawa Nobuyuki  

Pharmacogenomics, Vol. 14, Iss. 10, 2013-07 ,pp. : 1215-1225

Future Medicine

Access to resources Recommend Favorite

Aclidinium: In Chronic Obstructive Pulmonary Disease

By Frampton James E.  

Drugs, Vol. 72, Iss. 15, 2012-10 ,pp. : 1999-2011

Adis International

Access to resources Recommend Favorite